EDITORIAL
Published on 15 Jun 2022
Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
doi 10.3389/fphar.2022.916324
- 728 views
- 3 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
10k
Total downloads
37k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 07 Apr 2022
Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19
doi 10.3389/fphar.2022.805344
- 2,930 views
- 4 citations
REVIEW
Published on 04 Apr 2022
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
doi 10.3389/fphar.2022.806568
- 6,664 views
- 34 citations
ORIGINAL RESEARCH
Published on 08 Mar 2022
Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals
doi 10.3389/fphar.2021.812565
- 3,796 views
- 22 citations
REVIEW
Published on 21 Feb 2022
Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies
doi 10.3389/fphar.2022.801733
- 9,230 views
- 42 citations
ORIGINAL RESEARCH
Published on 14 Jan 2022
Preclinical Evaluation of Dimethyl Itaconate Against Hepatocellular Carcinoma via Activation of the e/iNOS-Mediated NF-κB–Dependent Apoptotic Pathway
doi 10.3389/fphar.2021.823285
- 2,471 views
- 10 citations
ORIGINAL RESEARCH
Published on 05 Jan 2022
Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants
doi 10.3389/fphar.2021.794325
- 2,824 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 Oct 2021
LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
doi 10.3389/fonc.2021.742789
- 2,048 views
- 29 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Respiratory Pharmacology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 37kTopic views
- 25kArticle views
- 10kArticle downloads